Editing
Bladder and Testis Oncology
(section)
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Testicular Tumors == * '''More likely benign in pre-pubertal males''' (in contrast to post-pubertal males where most testicular tumours are malignant) * Epidemiology ** ''The most common pathologic diagnosis in children with a testicular mass is a YST, followed by teratoma'' * '''Germ Cell Tumors''' ** '''Pathology''' *** '''Tertatoma''' **** ''According to some series, teratomas are the most common testicular tumor in children and consist of variable combinations of the three primitive embryologic germ cell layers [contradicts above]'' **** '''Consist of variable combinations of the three primitive embryologic germ cell layers''' **** '''Do not express AFP''' **** '''In contrast to teratoms in post-pubertal males, most teratomoas in pre-pubertal male are benign, consisting of mature elements only''', and do not metastasize **** '''Preferred treatment for suspected teratoma is partial orchiectomy''' *** '''Epidermoid cysts''' **** Benign lesion; represent a monolayer teratoma **** May account for >15% of prepubertal testis lesions **** '''Do not express AFP''' **** '''Preferred treatment for suspected epidermoid cysts is partial orchiectomy''' **** No surveillance is required after treatment *** '''Yolk-sac tumour (YST)''' **** '''Pathology''' ***** '''Schiller-Duval bodies consist of a central blood vessel surrounded by two layers of tumor cells''' ****** '''Pathognomonic for YSTs.''' **** '''AFP levels are elevated ''' **** '''When metastases occur, YSTs often exhibit hematogenous spread to the lungs, without retroperitoneal disease.''' '''For these reasons retroperitoneal lymph node dissection (RPLND) plays very little role in pre-pubertal YST.''' ***** RPLND is used exclusively for patients with a residual retroperitoneal mass or persistently elevated AFP after chemotherapy and orchiectomy ** '''Presentation, Evaluation, and Staging''' *** '''See CW11 Figure 156-7''' *** '''Ultrasonography''' **** '''Teratomas''' ***** '''Heterogeneous complex lesions and may contain cystic and solid components.''' ***** Bony elements appear as calcifications with shadowing. ***** Adipose tissue appears as echogenic areas without shadowing. **** '''Epidermoid cysts''' ***** Characteristic appearance described as '''“onion skin” comprised of concentric rings''' of alternating hypoechoic and hyperechoic lesions. **** YSTs ***** Typically well circumscribed and heterogeneous in appearance. ***** May appear hypervascular and may have areas of hemorrhage and necrosis. **** Sertoli and Leydig cell tumors ***** Similar in appearance ***** Commonly manifest as a well-circumscribed hypoechoic mass. *** '''Labs''' **** '''Tumour markers''' ***** '''Interpretation of AFP levels in infants undergoing evaluation for a testis mass must be performed with caution as a result of the physiologically persistent elevation of AFP in infants age < 1''' * Tumors Associated with Disorders of Sexual Differentiation ** See Disorders of Sexual Differentiation Chapter Notes ** Patients with dysgenetic testis or hypovirulization have an increased incidence of testicular tumors * '''Gonadal Stromal Tumors''' ** Juvenile granulosa cell tumors *** Most common testicular tumors affecting neonates ** '''Leydig cell tumors''' *** Hormonally active; associated with precocious puberty. ** '''Sertoli cell''' *** Usual presentation is a painless mass *** Associated with endocrinologic and genetic syndromes such as Peutz-Jeghers and Carney syndromes *** 10% are hormonally active * Leukemia and Lymphoma ** The most common cancers with metastases to the testis are leukemia and lymphoma
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information